HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammad Nasehi Selected Research

5-HT4 Serotonin Receptors

1/2020The role of 5-HT4 serotonin receptors in the CA1 hippocampal region on memory acquisition impairment induced by total (TSD) and REM sleep deprivation (RSD).
2/2016Effect of nucleus accumbens shell 5-HT4 receptors on the impairment of ACPA-induced emotional memory consolidation in male Wistar rats.
7/2015The Role of Hippocampal 5HT3 Receptors in Harmaline-Induced Memory Deficit.
3/2014Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohammad Nasehi Research Topics

Disease

32Amnesia (Dissociative Amnesia)
06/2021 - 10/2009
19Memory Disorders (Memory Loss)
06/2021 - 01/2013
15Sleep Deprivation
02/2022 - 01/2016
12Cholestasis
10/2021 - 11/2011
4Cognitive Dysfunction
04/2022 - 11/2013
4Hepatic Encephalopathy
12/2020 - 02/2013
4Pain (Aches)
01/2020 - 09/2017
3B-Cell Lymphoma (Lymphoma, B Cell)
08/2021 - 01/2020
3Alzheimer Disease (Alzheimer's Disease)
03/2021 - 04/2014
2Stroke (Strokes)
04/2022 - 01/2020
2Multiple Sclerosis
04/2022 - 02/2020
2Mental Disorders (Mental Disorder)
01/2022 - 01/2020
2Inflammation (Inflammations)
12/2020 - 01/2017
1Necrosis
06/2022
1Autism Spectrum Disorder
06/2022
1Schizophrenia (Dementia Praecox)
04/2022
1Neuroinflammatory Diseases
10/2021
1Ischemic Stroke
07/2021
1Sleep Wake Disorders
10/2020
1Substance-Related Disorders (Drug Abuse)
06/2020
1Hyperalgesia
01/2019
1Autistic Disorder (Autism)
05/2018
1Neurodevelopmental Disorders
05/2018

Drug/Important Bio-Agent (IBA)

8harman (harmane)IBA
09/2019 - 05/2010
7SCH 23390IBA
01/2021 - 02/2013
7Sulpiride (neogama)IBA
01/2021 - 02/2013
7Anti-Anxiety Agents (Anxiolytics)IBA
10/2017 - 11/2011
7Naloxone (Narcan)FDA LinkGeneric
10/2016 - 11/2011
6CannabinoidsIBA
01/2021 - 01/2015
6CB1 Cannabinoid Receptor (CB1 Receptor)IBA
02/2016 - 10/2009
5NeuroaidIBA
08/2021 - 01/2019
5RS 67333IBA
06/2021 - 03/2014
5Scopolamine (Hyoscine)FDA Link
01/2021 - 03/2012
5Morphine (MS Contin)FDA LinkGeneric
06/2020 - 03/2012
5Opioid Analgesics (Opioids)IBA
01/2019 - 11/2011
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2017 - 10/2011
4Dopamine AntagonistsIBA
01/2021 - 08/2013
45-HT4 Serotonin ReceptorsIBA
01/2020 - 03/2014
4Pharmaceutical PreparationsIBA
01/2018 - 10/2009
4Dopamine (Intropin)FDA LinkGeneric
08/2013 - 05/2010
3Therapeutic UsesIBA
04/2022 - 02/2020
3AntioxidantsIBA
10/2021 - 06/2020
3salicylhydroxamic acid (SHAM)IBA
03/2021 - 06/2013
3AM 251 (AM251)IBA
01/2021 - 10/2009
3MuscimolIBA
01/2018 - 01/2015
3Cholinergic Agents (Cholinergics)IBA
10/2017 - 03/2012
3azasetronIBA
09/2017 - 03/2014
3Dizocilpine Maleate (Dizocilpine)IBA
04/2016 - 10/2011
3mu Opioid Receptors (mu Opioid Receptor)IBA
04/2014 - 06/2013
3N-Methylaspartate (NMDA)IBA
11/2013 - 10/2011
3NG-Nitroarginine Methyl Ester (L-NAME)IBA
06/2013 - 03/2012
2Thimerosal (Thiomersal)IBA
06/2022 - 05/2018
2crocinIBA
10/2021 - 06/2021
2Proteins (Proteins, Gene)FDA Link
08/2021 - 01/2020
2Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2021 - 01/2019
2Yohimbine (Yocon)IBA
01/2020 - 01/2016
2Clonidine (ST 155)FDA LinkGeneric
01/2020 - 01/2016
2Dopamine Agents (Dopaminergic Agents)IBA
09/2019 - 10/2012
2Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
10/2017 - 04/2014
2AlkaloidsIBA
12/2016 - 05/2010
2Adrenergic Receptors (Adrenergic Receptor)IBA
01/2016 - 01/2016
2arachidonylcyclopropylamideIBA
11/2015 - 04/2015
2HarmalineIBA
07/2015 - 10/2014
2Arginine (L-Arginine)FDA Link
06/2013 - 01/2013
1Immunologic Factors (Immunomodulators)IBA
02/2022
1EpitopesIBA
02/2022
1LithiumIBA
01/2022
1CatalaseIBA
10/2021
1Superoxide DismutaseIBA
10/2021
1punicalaginIBA
03/2021
1Inflammation MediatorsIBA
03/2021
1Lithium ChlorideIBA
01/2021
1Amyloid (Amyloid Fibrils)IBA
12/2020
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
12/2020
1mitochondrial transcription factor AIBA
12/2020
1propionic acid (potassium propionate)IBA
12/2020
1CurcuminIBA
12/2020
1alpha-2 Adrenergic ReceptorsIBA
12/2020
1Oxidoreductases (Dehydrogenase)IBA
10/2020
1Cocaine (Cocaine HCl)IBA
06/2020
1Neuroprotective AgentsIBA
06/2020
1NeuropeptidesIBA
06/2020
1Amphetamine (Amfetamine)FDA LinkGeneric
06/2020
1Free RadicalsIBA
01/2020
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2020
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
12,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA
09/2019
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019
1Streptozocin (Streptozotocin)FDA Link
01/2019
1Opiate AlkaloidsIBA
01/2019
1Dopamine D2 Receptor AntagonistsIBA
01/2019
1Dopamine Receptors (Dopamine Receptor)IBA
01/2019

Therapy/Procedure

12Ligation
10/2021 - 11/2011
5Injections
09/2019 - 10/2009
4Transcranial Direct Current Stimulation
01/2021 - 11/2017
4Analgesia
01/2019 - 09/2017
3Cognitive Training
04/2022 - 01/2020
1Activities of Daily Living (ADL)
01/2020
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2019